Search

Your search keyword '"Marta Canelo-Vilaseca"' showing total 8 results
Start Over Author "Marta Canelo-Vilaseca"
8 results on '"Marta Canelo-Vilaseca"'

1. HHV8 and EBV‐negative primary effusion‐based lymphoma: A case report of a new provisional entity and review of literature

Author

Marta Canelo‐Vilaseca, Gustavo Tapia, Elisa Orna, Marc Sorigué, Isabel Granada, Azahara Palomar‐Muñoz, Ana Castillo, Javier Grau, Alba Mesa, Josep‐Maria Ribera, Juan‐Manuel Sancho, and José‐Tomás Navarro

Subjects
HHV8 and EBV‐negative primary effusion‐based lymphoma, PEL, PEL‐like, Medicine, Medicine (General), R5-920
Abstract

Key Clinical Message HHV8‐ and EBV‐negative primary effusion lymphoma is an extremely rare neoplasm involving body cavities without detectable tumor mass. It usually presents in elderly patients without known immunodeficiency. Compared to primary effusion lymphoma, it has a better prognosis. Primary effusion lymphoma (PEL) is a rare non‐Hodgkin lymphoma confined exclusively to body cavities without detectable tumor masses. The term PEL‐like is an entity similar to PEL in clinical presentation but without relation to human herpesvirus 8 (HHV8). We report a case of HHV8‐ and EBV‐negative primary effusion‐based lymphoma.

Published
2023
Full Text
View/download PDF

2. Rituximab Maintenance (RM) after First-Line (1L) Treatment Is Associated with a Lower Risk of Early-POD in Patients with Mantle Cell Lymphoma (MCL)

Author

Alba Cabirta, Pau Abrisqueta, Víctor Navarro Garcés, Marta Canelo-Vilaseca, Marina Gomez-Rosa, Alberto Lopez García, Tomas García, Fatima De la Cruz, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Moraima Jiménez, Sabela Bobillo, Marta Julia, Cecilia Carpio, Gloria Iacoboni, Laura Gallur, Josep Castellvi, Francesc Bosch, and Ana Marin-Niebla

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022

3. HHV8 and EBV negative primary effusion-based lymphoma: a case report of a new provisional entity and review of literature

Author

Marta Canelo-Vilaseca, Gustavo Tapia Melendo, Elisa Orna, Marc Sorigué, Isabel Granada, Azahara Palomar-Muñoz, Ana Castillo, Javier Grau, Alba Mesa, Josep-Maria Ribera, Juan Manuel Sancho, and Jose-Tomas Navarro

Abstract

Primary effusion lymphoma (PEL) is a rare non-Hodgkin lymphoma confined exclusively to body cavities without detectable tumor masses. The term PEL-like is an entity similar to PEL in clinical presentation but without relation to human herpesvirus 8 (HHV8). We report a case of HHV8- and EBV-negative primary effusion-based lymphoma.

Published
2022

6. P-203: Early mortality and treatment discontinuation in multiple myeloma patients treated in front-line with bortezomib, lenalidomide and dexamethasone (VRD)

Author

Albert Oriol, Marta Canelo-Vilaseca, Carla Sanchez, Laura Abril, Lourdes Escoda, Gladys Ibarra, Eugenia Abella, Cristina Motllo, Yolanda Gonzalez-Montes, Isabel Granada, Elena Cabezudo, Alicia Senin, Randa Ben, Rebeca Jurado, Alejandro de Jaureguizar, Josep-Maria Ribera, Josep Sarra, Juan-Manuel Sancho, and Anna Sureda

Subjects
Cancer Research, Oncology, Hematology
Published
2022

7. Colitis due to idelalisib in a patient with follicular lymphoma

Author

Marta, Canelo-Vilaseca, Josep-Maria, Ribera Santasusana, and Juan-Manuel, Sancho Cia

Subjects
Purines, Humans, Antineoplastic Agents, General Medicine, Colitis, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Follicular, Quinazolinones
Published
2022

Catalog

Books, media, physical & digital resources
See catalog results